InsidersTradesSigma
Follow the 富祥股份 share price and the full insider trade history of the company, a listed equity based in China. Shares are quoted on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 富祥股份 has logged 14 reports. Market capitalisation: €9.1bn. The latest transaction was disclosed on 26 June 2024 (Purchase). Among the most active insiders: 柯丹. The full history is openly available.
14
Insider Decl.
n/a
Thresholds
€10m
13 ops.
Buy Volume
€2,936
1 ops.
Sell Volume
18Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,438 of 28,985 companies
24.3
score / 100
Value31
Quality18
FCF yld-1.8%
Earn yld-0.6%
EV/EBITDA·
ROE-0.2%
Gross mgn17%
Net mgn-4.6%
Debt/EBITDA9.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 26 June 2024
Declarations14 total
14 of 14 declarations
About 富祥股份
富祥股份 is a company in the health and pharmaceutical sector, listed on the XSHE market. It specializes in the development and production of pharmaceutical products.